Lanean...
Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study
As tocilizumab (TCZ) greatly inhibits inflammatory markers, methods of evaluating rheumatoid arthritis (RA) disease activity that include inflammatory markers may overestimate the effect of TCZ treatment. We have evaluated the impact of inflammatory markers on the efficacy of TCZ by comparing the ef...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Texto |
| Hizkuntza: | English |
| Argitaratua: |
Springer Japan
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999727/ https://www.ncbi.nlm.nih.gov/pubmed/20617358 http://dx.doi.org/10.1007/s10165-010-0328-0 |